First-Line Treatment for Hypertension
The first-line treatment for hypertension should include thiazide diuretics, ACE inhibitors, ARBs, or calcium channel blockers, with thiazide-like diuretics being preferred due to their proven efficacy in reducing cardiovascular events. 1, 2
Initial Medication Selection Algorithm
Step 1: Assess Patient Characteristics
- For patients without comorbidities: Thiazide-like diuretics (chlorthalidone preferred over hydrochlorothiazide) 1, 3
- For patients with albuminuria (UACR ≥30 mg/g): ACE inhibitor or ARB 1
- For patients with diabetes and albuminuria: ACE inhibitor or ARB 1
- For patients with coronary artery disease: ACE inhibitor or ARB 1, 2
Step 2: Consider Severity of Hypertension
Medication Options and Evidence
Thiazide Diuretics
- Preferred first-line agent with strongest evidence for reducing cardiovascular events 1, 3
- Chlorthalidone is preferred over hydrochlorothiazide due to superior efficacy and outcomes 4, 3
- Dosing: Chlorthalidone 12.5-25 mg daily 2
ACE Inhibitors
- Effective for reducing cardiovascular events and mortality 1, 5
- Particularly beneficial for patients with albuminuria, diabetes, or heart failure 1
- Example: Lisinopril 10-40 mg daily 5
Angiotensin Receptor Blockers (ARBs)
- Alternative to ACE inhibitors when not tolerated (less cough and angioedema) 1, 2
- Equally effective for patients with albuminuria 1
Calcium Channel Blockers
- Dihydropyridine type (e.g., amlodipine) is preferred 1, 6
- Particularly effective in black patients 1
- Dosing: Amlodipine 2.5-10 mg daily 6
Combination Therapy Considerations
For patients requiring multiple medications:
- Thiazide diuretic + ACE inhibitor or ARB
- Calcium channel blocker + ACE inhibitor or ARB
- Calcium channel blocker + thiazide diuretic
Avoid these combinations 1:
- ACE inhibitor + ARB (increased adverse effects without additional benefit)
- ACE inhibitor or ARB + direct renin inhibitor
Special Populations
Black Patients
- Thiazide diuretics or calcium channel blockers are more effective than ACE inhibitors 1
Elderly Patients (≥65 years)
Resistant Hypertension
- Add mineralocorticoid receptor antagonist (spironolactone 25-50 mg) when three-drug regimen including a diuretic fails 1, 2
Monitoring
- For patients on ACE inhibitors, ARBs, or diuretics: Monitor serum creatinine/eGFR and potassium at least annually 1
- Monitor for orthostatic hypotension, especially in elderly patients 2
Common Pitfalls to Avoid
- Using beta-blockers as first-line therapy (less effective than other classes for primary prevention) 1
- Using hydrochlorothiazide instead of chlorthalidone (chlorthalidone has better evidence) 3
- Combining ACE inhibitors with ARBs (increases adverse effects without additional benefit) 1
- Delaying combination therapy in patients with stage 2 hypertension (BP ≥160/100 mmHg) 1
- Not considering drug interactions (e.g., NSAIDs can reduce effectiveness of ACE inhibitors) 2
By following this evidence-based approach to selecting first-line antihypertensive therapy, clinicians can optimize blood pressure control and reduce cardiovascular morbidity and mortality in patients with hypertension.